top 10 things to know about emcure pharmaceuticals ipo | namita thapar's emcure pharma ipo review
Published 1 month ago • 12K plays • Length 4:34Download video MP4
Download video MP3
Similar videos
-
16:05
emcure pharma ipo summary | ca rachana ranade
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
7:27
emcure pharmaceuticals ipo - apply or not? | emcure pharmaceuticals ipo review
-
2:26
‘shark’ namita thapar’s investment swells 38,200% after strong emcure pharma listing! | details
-
15:07
emcure pharma's ipo | growth plans ahead? anil singhvi in talk with namita thapar & samit mehta
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
4:17
emcure pharmaceuticals ipo review | issue details, financials, products | namita thapar | must watch
-
4:34
akums drugs and pharmaceuticals ipo review | akums drugs and pharmaceuticals ipo gmp today
-
8:41
emcure pharma ipo oversubscribed; growth & expansion plans | samit mehta & vikas thapar | et now
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
8:00
emcure pharma ipo - opportunity or high valuation? | emcure pharma analysis |
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
4:06
emcure pharma ipo: all you need to know before investing
-
17:12
namita thapar's emcure pharma ipo - apply or avoid? expected listing gain? vibhor varshney
-
0:51
emcure pharma ipo good or bad to invest?
-
9:19
✅ emcure pharma ipo review | emcure pharma ipo gmp analysis | emcure pharma se kitna listing gain mi
-
1:14
namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
-
0:48
namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
-
19:33
everything you need to know about emcure pharmaceuticals ipo
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18